Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Hair transplant complications are rare with good planning and technique, but risks include infection, bleeding, and patient dissatisfaction.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

New tests detect finasteride and dutasteride in urine quickly and easily.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.

Finasteride helps reduce heart enlargement in heart failure patients.

Microneedling combined with skinbooster effectively treats striae rubrae, with confocal microscopy confirming collagen changes.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Cronkhite-Canada syndrome can sometimes show unusual colonic adenomatous polyps.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

A new low-cost method can accurately detect PCOS early by measuring free testosterone levels.